Article
Gastroenterology & Hepatology
Charlotte Desprez, Audrey Grange, Guillaume Gourcerol, Alexis Deperrois, Oriane Garconnet, Clemence Leroux, Gregory Mosni, Laurence Poux, Justine Breemeersch, Cecile Goblot, Sebastien Kepka, Julie Ruillon, Margot Vannier, Valerie Bridoux, Anne-Marie Leroi
Summary: Regular follow-up and reprogramming of stimulation parameters in patients with implanted SNM devices can optimize the efficacy of treatment for fecal incontinence.
COLORECTAL DISEASE
(2022)
Article
Gastroenterology & Hepatology
Anthony Y. Lin, Chris Varghese, Niranchan Paskaranandavadivel, Sean Seo, Peng Du, Phil Dinning, Ian P. Bissett, Greg O'Grady
Summary: The rectosigmoid brake was suppressed in patients with faecal incontinence, and sacral neuromodulation (SNM) may exert a therapeutic effect by modulating this rectosigmoid brake.
COLORECTAL DISEASE
(2022)
Article
Gastroenterology & Hepatology
K. Ong, L. Bordeianou, M. Brunner, S. Buntzen, M. H. S. Collie, A. Hanly, C. W. Hunt, K. E. Matzel, P. R. O'Connell, M. Rydningen, L. Savitt, A. Totaro, C. J. Vaizey, Y. Maeda
Summary: This study aimed to determine whether the paradigm of surgical intervention for faecal incontinence has changed between 2000 and 2013. The results showed an increasing use of sacral neuromodulation over time, indicating a shift in the surgical intervention paradigm for faecal incontinence.
COLORECTAL DISEASE
(2021)
Article
Gastroenterology & Hepatology
C. Seifarth, N. Slavova, C. Degro, K. S. Lehmann, M. E. Kreis, B. Weixler
Summary: This study evaluated the use of sacral nerve stimulation (SNS) in patients with high stool frequency or fecal incontinence after proctocolectomy with IPAA. The results showed that SNS improved symptoms in over two-thirds of patients, suggesting its feasibility as a therapeutic option in this patient population.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
(2021)
Article
Pediatrics
Stephen Trinidad, Amanda Jensen, Monica Holder, Allison Elsner, Nelson Rosen, Aaron Garrison, Beth Rymeski, Jason S. Frischer
Summary: This study evaluated the outcomes of sacral nerve stimulation (SNS) in patients with medically refractory fecal incontinence or severe constipation. A retrospective cohort study was conducted on patients who underwent SNS placement after failed medical management at a single center. The rates of involuntary bowel movements were compared pre- and post-SNS using a bowel severity score questionnaire.
JOURNAL OF PEDIATRIC SURGERY
(2023)
Article
Clinical Neurology
Luigi Valentino Berra, Daniele Armocida, Mauro Palmieri, Valerio Di Norcia, Luca D'Angelo, Massimo Mongardini, Massimo Vigliotta, Edoardo Maccari, Antonio Santoro
Summary: Reconstructing sacrificed nerves during sacral tumor removal has been proven effective in restoring sphincter and sexual function, offering promising potential to significantly enhance patients' quality of life.
Article
Medicine, General & Internal
Christopher Dawoud, Leonhard Bender, Kerstin Melanie Widmann, Felix Harpain, Stefan Riss
Summary: Sphinkeeper implantation is a promising surgical technique for severe fecal incontinence, with low complication rates and short-term functional improvement. However, implant migration is commonly observed in patients undergoing this procedure.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Gastroenterology & Hepatology
Mario de Miguel J. Valencia, Juan Cabases M. Hita, Eduardo Sanchez Iriso, Fabiola Oteiza Martinez, Inaki Alberdi Ibanez, Alfonso Alvarez Lopez, Hector Ortiz Hurtado, Mario J. de Miguel J. Velasco
Summary: The aim of this study was to evaluate the long-term cost-effectiveness of sacral neuromodulation in the treatment of severe faecal incontinence as compared with symptomatic management. The results showed that sacral neuromodulation may be considered a cost-effective technique in the long-term treatment of severe faecal incontinence from the societal and health care sector perspectives, with incremental cost-effectiveness ratios of 14347euro/QALY and 28523euro/QALY, respectively.
COLORECTAL DISEASE
(2023)
Article
Surgery
Luigi Brusciano, Antonio Brillantino, Gianluca Pellino, Franco Marinello, Coen I. M. Baeten, Alex Digesu, Gabriele Naldini, Claudio Gambardella, Francesco Saverio Lucido, Alessandro Sturiale, Giorgia Gualtieri, Stefan Riss, Ludovico Docimo
Summary: Sacral nerve modulation is a safe and effective treatment for fecal and double incontinence, improving symptoms, quality of life, and sexual function in the long term.
UPDATES IN SURGERY
(2023)
Article
Gastroenterology & Hepatology
M. Bosch-Ramirez, L. Sanchez-Guillen, M. J. Alcaide-Quiros, M. M. Aguilar-Martinez, M. Bellon-Lopez, A. Lopez Delgado, F. Lopez-Rodriguez-Arias, A. Munoz-Duyos, X. Barber-Valles, A. Arroyo
Summary: This study evaluated the long-term efficacy of percutaneous tibial nerve stimulation (PTNS) for patients with refractory faecal incontinence (FI), and found that after 1 year of treatment, the majority of patients achieved optimal responses, and even those who initially had only partial responses maintained long-term continence after 3 years.
TECHNIQUES IN COLOPROCTOLOGY
(2023)
Article
Gastroenterology & Hepatology
Judith Evers, P. Ronan O'Connell, James F. X. Jones
Summary: This study investigated the changes in the transmission of sensory anorectal stimuli in a rodent model of fecal incontinence and the effects of sacral nerve stimulation on defecation behavior. The results showed that chronic sacral nerve stimulation using miniature telemetric devices is feasible in rats and can improve fecal incontinence symptoms. The amplitude of anorectal evoked potentials was found to be negatively correlated with the behavioral signs of fecal incontinence.
DISEASES OF THE COLON & RECTUM
(2022)
Article
Urology & Nephrology
Jacqueline Zillioux, Kevin C. Lewis, Daniel Hettel, Howard B. Goldman, Sandip P. Vasavada, Bradley C. Gill
Summary: This study aimed to evaluate the impact of cognitive impairment (CI) diagnoses on sacral neuromodulation (SNM) outcomes in older patients with overactive bladder (OAB). The study found that a diagnosis of CI does not affect the implantation rates of SNM therapy for refractory OAB. Therefore, patients with OAB and CI diagnoses should not be excluded from SNM therapy.
NEUROUROLOGY AND URODYNAMICS
(2023)
Article
Gastroenterology & Hepatology
Guillaume Meurette, Laurent Siproudhis, Anne-Marie Leroi, Henri Damon, David Urs Josef Keller, Jean-Luc Faucheron
Summary: This study confirms the clinical effectiveness, safety, and positive effect of sacral neuromodulation with the InterStim(TM) system for the treatment of faecal incontinence, showing significant improvements in quality of life and symptoms with high patient satisfaction. Main device-related adverse events include the need for reprogramming, infection, and surgical revision.
COLORECTAL DISEASE
(2021)
Article
Otorhinolaryngology
James T. Heaton, James B. Kobler, Mark P. Ottensmeyer, Robert H. Petrillo, Monica A. Tynan, Robert E. Hillman, Steven M. Zeitels
Summary: A new method for tracking recovery after nerve injury was studied, using subcutaneous electrical connection ports to repeatedly connect to nerve cuff or intramuscular electrodes for periodic assessments of nerve and muscle function over long periods.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
(2021)
Article
Gastroenterology & Hepatology
Assia Daikh, Fabienne Reymond, Dorothee Lombardo, Caroline Thuillier, Pierrick Bedouch, Jean-Luc Faucheron
Summary: Sacral nerve neuromodulation (SNM) is a safe and effective therapy for managing fecal and/or urinary incontinence. This study evaluated the lifespan of InterStim(TM) and InterStim(TM) II generators and the long-term hospital costs associated with SNM therapy. The results showed that the lifespan of InterStim(TM) II is shorter than the first-generation device, leading to increased hospital costs over time.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
(2023)
